CRESCENDO: ChildREn's muSiC ENhancement in Cochlear Implant Users
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-19
SponsorSeoul National University Hospital
About this trial
This exploratory, single-center, single-arm study investigates the impact of a 12-week Multimodal Acoustic Therapy (MAT) intervention followed by a 12-week follow-up period on both objective and subjective auditory perception in pediatric cochlear implant users.
Eligibility criteria
Qualifiers
Individuals with cochlear implants
Korean patients aged 10 to 19 years
Capable of using a smartphone
Scored ≤80% on MCI pre-assessment
Disqualifiers
Has systemic medical conditions (e.g., cancer, stroke) that limit daily functioning
Has intellectual disability, congenital malformation, or other neurological disorders affecting language or cognitive abilities
Has diagnosed emotional disorders such as depression or anxiety
Primarily uses sign language for daily communication
Trial design
Treatments tested in this trial
- Mobile Auditory Rehabilitation
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Seoul National University Hospital
Lead sponsor
BELL Therapeutics Inc.
Collaborator
Source ClinicalTrials.gov